We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
AUM
$17.8B
AUM Growth
+$2.97B
Cap. Flow
+$1.92B
Cap. Flow %
10.82%
Top 10 Hldgs %
20.72%
Holding
3,755
New
435
Increased
1,757
Reduced
754
Closed
214

Top Sells

Rank Stock Value
1
AFL icon
Aflac
AFL
+$122M
2
CERN
Cerner Corp
CERN
+$79.8M
3
MSFT icon
Microsoft
MSFT
+$76.7M
4
AEM icon
Agnico Eagle Mines
AEM
+$60.1M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$47.2M

Sector Composition

Rank Sector Weight
1 Technology 20.15%
2 Financials 14.33%
3 Healthcare 12.64%
4 Consumer Discretionary 8.27%
5 Industrials 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMBI
2901
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$7K ﹤0.01%
387
CVA
2902
DELISTED
Covanta Holding Corporation
CVA
$7K ﹤0.01%
437
-1,120
-72% -$17K
NBO
2903
DELISTED
Neuberger Berman New York Municipal Fund Inc.
NBO
$7K ﹤0.01%
555
AIN icon
2904
Albany International
AIN
$1.78B
$6K ﹤0.01%
77
-31
-29% -$2.71K
ALE
2905
DELISTED
Allete
ALE
$6K ﹤0.01%
+100
New +$6.97K
ALEX
2906
DELISTED
Alexander & Baldwin
ALEX
$6K ﹤0.01%
337
+2
+0.6% +$37
ARCT icon
2907
Arcturus Therapeutics
ARCT
$212M
$6K ﹤0.01%
192
ARMK icon
2908
Aramark
ARMK
$14.7B
$6K ﹤0.01%
276
-81
-23% -$2.22K
ASB icon
2909
Associated Banc-Corp
ASB
$5.91B
$6K ﹤0.01%
324
+2
+0.6% +$44
ASND icon
2910
Ascendis Pharma A/S
ASND
$16.8B
$6K ﹤0.01%
50
BKF icon
2911
iShares MSCI BIC ETF
BKF
$78.8M
$6K ﹤0.01%
126
SRTA
2912
Strata Critical Medical Inc
SRTA
$520M
$6K ﹤0.01%
610
-1,150
-65% -$11.4K
BRSP
2913
BrightSpire Capital
BRSP
$650M
$6K ﹤0.01%
714
+8
+1% +$74
CHRS icon
2914
Coherus Oncology
CHRS
$199M
$6K ﹤0.01%
441
CII icon
2915
BlackRock Enhanced Captial and Income Fund
CII
$1.01B
$6K ﹤0.01%
300
CRVS icon
2916
Corvus Pharmaceuticals
CRVS
$1.15B
$6K ﹤0.01%
2,500
CWST icon
2917
Casella Waste Systems
CWST
$5.63B
$6K ﹤0.01%
106
+24
+29% +$1.59K
DWLD icon
2918
Davis Select Worldwide ETF
DWLD
$613M
$6K ﹤0.01%
200
ECON icon
2919
Columbia Emerging Markets Consumer ETF
ECON
$336M
$6K ﹤0.01%
226
-15
-6% -$416
EEFT icon
2920
Euronet Worldwide
EEFT
$2.69B
$6K ﹤0.01%
56
-11
-16% -$1.6K
ESRT icon
2921
Empire State Realty Trust
ESRT
$836M
$6K ﹤0.01%
541
+1
+0.2% +$12
EVTC icon
2922
Evertec
EVTC
$1.79B
$6K ﹤0.01%
+145
New +$6.12K
FCPT icon
2923
Four Corners Property Trust
FCPT
$2.75B
$6K ﹤0.01%
222
+40
+22% +$1.13K
FIZZ icon
2924
National Beverage
FIZZ
$3.01B
$6K ﹤0.01%
+139
New +$6.74K
GBCI icon
2925
Glacier Bancorp
GBCI
$6.37B
$6K ﹤0.01%
120
-46
-28% -$2.69K

Similar funds

Rockefeller Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Rockefeller Capital Management held 3,755 positions worth $17.8B, up 20% from $14.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Rockefeller Capital Management deployed $1.92B of net new capital in Q2 2021, opening 435 new positions and adding to 1,757 existing holdings. Its largest new stake was Mueller Industries: 1,424,220 shares worth $15.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Aflac, an estimated $122M trimmed.

  • Rockefeller Capital Management's largest Q2 2021 buy was Mueller Industries: 1,424,220 shares worth $15.4M.
  • Rockefeller Capital Management added most to Coherent in Q2 2021, an estimated $66.3M increase.
  • Rockefeller Capital Management's biggest Q2 2021 reduction was Aflac, cutting an estimated $122M.
  • Rockefeller Capital Management fully exited NIC Inc in Q2 2021, selling an estimated $30.3M.
  • Rockefeller Capital Management's ten largest holdings make up 21% of its $17.8B portfolio in Q2 2021.
  • Rockefeller Capital Management opened 435 new positions and closed 214 in Q2 2021.
  • Rockefeller Capital Management's portfolio value rose 20% quarter-over-quarter to $17.8B.

Based on Rockefeller Capital Management's 13F filing for Q2 2021, filed 10 Aug 2021.